FRESENIUS SE & CO KGAA (FRE.DE) Fundamental Analysis & Valuation

FRA:FRE • DE0005785604

Current stock price

41.25 EUR
-0.15 (-0.36%)
Last:

This FRE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FRE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FRE was profitable.
  • In the past year FRE had a positive cash flow from operations.
  • FRE had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.05%, FRE is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
  • With a Return On Equity value of 6.62%, FRE perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
  • FRE's Return On Invested Capital of 4.90% is in line compared to the rest of the industry. FRE outperforms 48.15% of its industry peers.
Industry RankSector Rank
ROA 3.05%
ROE 6.62%
ROIC 4.9%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Profit Margin of FRE (5.53%) is better than 88.89% of its industry peers.
  • In the last couple of years the Profit Margin of FRE has grown nicely.
  • FRE has a better Operating Margin (10.10%) than 88.89% of its industry peers.
  • FRE's Operating Margin has declined in the last couple of years.
  • The Gross Margin of FRE (24.89%) is comparable to the rest of the industry.
  • FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.1%
PM (TTM) 5.53%
GM 24.89%
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

5

2. FRE.DE Health Analysis

2.1 Basic Checks

  • FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for FRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • FRE has an Altman-Z score of 2.08. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FRE's Altman-Z score of 2.08 is fine compared to the rest of the industry. FRE outperforms 70.37% of its industry peers.
  • The Debt to FCF ratio of FRE is 10.99, which is on the high side as it means it would take FRE, 10.99 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 10.99, FRE perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
  • FRE has a Debt/Equity ratio of 0.57. This is a neutral value indicating FRE is somewhat dependend on debt financing.
  • FRE's Debt to Equity ratio of 0.57 is amongst the best of the industry. FRE outperforms 85.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 10.99
Altman-Z 2.08
ROIC/WACC0.73
WACC6.74%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.32. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, FRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • FRE has a Quick Ratio of 1.00. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.00, FRE is doing good in the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. FRE.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.31% over the past year.
  • FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.06% yearly.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 4.76% in the last year.
  • FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.81% yearly.
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%

3.2 Future

  • FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.53% yearly.
  • Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 5.44% on average per year.
EPS Next Y15.7%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
EPS Next 5Y10.53%
Revenue Next Year5.05%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

5

4. FRE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.89, the valuation of FRE can be described as correct.
  • Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
  • FRE is valuated cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 11.14 indicates a reasonable valuation of FRE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FRE indicates a rather cheap valuation: FRE is cheaper than 85.19% of the companies listed in the same industry.
  • FRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.75.
Industry RankSector Rank
PE 12.89
Fwd PE 11.14
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • FRE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.57
EV/EBITDA 8.95
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y12.8%
EPS Next 3Y11.2%

4

5. FRE.DE Dividend Analysis

5.1 Amount

  • FRE has a Yearly Dividend Yield of 2.58%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.64, FRE pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, FRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.58%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 54.11% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP54.11%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRE.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (4/30/2026, 7:00:00 PM)

41.25

-0.15 (-0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength14.19
Industry Growth80.67
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners45.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.23B
Revenue(TTM)22.87B
Net Income(TTM)1.26B
Analysts85.22
Price Target57.32 (38.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP54.11%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.66%
Min EPS beat(2)-28.85%
Max EPS beat(2)13.53%
EPS beat(4)3
Avg EPS beat(4)2.8%
Min EPS beat(4)-28.85%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)2.89%
EPS beat(12)7
Avg EPS beat(12)-36.01%
EPS beat(16)8
Avg EPS beat(16)-32.65%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)-1.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.46%
Revenue beat(16)6
Avg Revenue beat(16)-0.35%
PT rev (1m)1.68%
PT rev (3m)2.44%
EPS NQ rev (1m)-1.57%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-3.22%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 12.89
Fwd PE 11.14
P/S 1.02
P/FCF 21.57
P/OCF 9.03
P/B 1.22
P/tB 9.73
EV/EBITDA 8.95
EPS(TTM)3.2
EY7.76%
EPS(NY)3.7
Fwd EY8.98%
FCF(TTM)1.91
FCFY4.64%
OCF(TTM)4.57
OCFY11.08%
SpS40.61
BVpS33.92
TBVpS4.24
PEG (NY)0.82
PEG (5Y)N/A
Graham Number49.4176 (19.8%)
Profitability
Industry RankSector Rank
ROA 3.05%
ROE 6.62%
ROCE 7%
ROIC 4.9%
ROICexc 5.22%
ROICexgc 11.15%
OM 10.1%
PM (TTM) 5.53%
GM 24.89%
FCFM 4.71%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 10.99
Debt/EBITDA 3.17
Cap/Depr 133.66%
Cap/Sales 6.54%
Interest Coverage 6.28
Cash Conversion 75.04%
Profit Quality 85.21%
Current Ratio 1.32
Quick Ratio 1
Altman-Z 2.08
F-Score7
WACC6.74%
ROIC/WACC0.73
Cap/Depr(3y)103.18%
Cap/Depr(5y)90.15%
Cap/Sales(3y)5.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
EPS Next Y15.7%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
EPS Next 5Y10.53%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%
Revenue Next Year5.05%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.44%
EBIT growth 1Y29.27%
EBIT growth 3Y7.94%
EBIT growth 5Y-11.93%
EBIT Next Year52.22%
EBIT Next 3Y20.31%
EBIT Next 5Y13.91%
FCF growth 1Y-23.73%
FCF growth 3Y-22.13%
FCF growth 5Y-23.62%
OCF growth 1Y6.58%
OCF growth 3Y-15.04%
OCF growth 5Y-17.04%

FRESENIUS SE & CO KGAA / FRE.DE Fundamental Analysis FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 5 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


What is the profitability of FRE stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the valuation of FRESENIUS SE & CO KGAA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 12.89 and the Price/Book (PB) ratio is 1.22.


How financially healthy is FRESENIUS SE & CO KGAA?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 5 / 10.